Designed for pharmaceutical packaging (injectables, vaccines, serums), our glass ampoules meet ISO standards and hold Hydrolytic Resistance Level 1 – ensuring maximum safety and stability for sensitive pharmaceutical products.

1. Core Performance: Hydrolytic Resistance Level 1

   As the highest grade for pharmaceutical glass, Level 1 resistance prevents glass hydrolysis (ion leaching) even in contact with aqueous/acidic injectables. Maintains product purity and efficacy over shelf life, ideal for long-storage pharmaceuticals.

2. ISO Standard Compliance

   Adheres to strict ISO standards (e.g., ISO 9187) for dimensional accuracy, mechanical strength, and sterility. Ensures compatibility with global pharmaceutical production lines and meets regulatory requirements (USP/EP/JP).

3. Pharmaceutical-Grade Design
   • Tamper-evident: Sealed by melting the neck, eliminating contamination risk post-production.
   • Clear/amber options: Clear for visual inspection (particulates, discoloration); amber blocks UV light to protect light-sensitive drugs (e.g., certain vaccines).
   • Various capacities: Available in small volumes (0.5ml-10ml) – perfect for single-dose injectables, reducing waste.
4. Quality Assurance

   Every batch undergoes testing for hydrolytic resistance, seal integrity, and particle count. Provides Certificates of Analysis (CoA) to support pharmaceutical regulatory registration.

It has a production capacity of over 6 billion pieces of glass vial and galss ampoule annual output.

During the production process, the ampoule is inspected by a camera. To remove the pressure from the glass, the ampoules are annealed in an oven. At the end of the line, the product is robotically packed in polypropylene pallets.

Traceability system for all key manufacturing parameters (such as materials, equipment, operators, etc.) Traceability system for all key manufacturing parameters (such as materials, equipment, operators, etc.

2025 Pharmaconex in Eygpt

With 35 years development, Jingu has established good cooperation with over 300 pharmaceuticalcompanies. We're looking forward to building multual-trusted and multual beneficial parntership with you!